CHUNG-WELCH NANCY
Known title: DirectorCIK: 0001817690
Associated companies
Transaction History
| AGPU | ▲ Buy | Grant | 64,680 | $0 | 9/9/2025 | View on chart |
| AGPU | ▲ Buy | Grant | 2,353 | $0 | 4/5/2024 | View on chart |
| AGPU | ▲ Buy | Grant | 1,875 | $0 | 10/2/2023 | View on chart |
| AGPU | ▲ Buy | Grant | 2,675 | $0 | 7/3/2023 | View on chart |
| AGPU | ▲ Buy | Grant | 18,360 | $0 | 4/3/2023 | View on chart |
| AGPU | ▲ Buy | Grant | 97,848 | $0 | 1/3/2023 | View on chart |
| AGPU | ▲ Buy | Grant | 23,147 | $0 | 10/3/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 44,704 | $0 | 7/1/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 8,530 | $0 | 3/31/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 31,517 | $0 | 1/4/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 4,512 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business
Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business. Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.